Clinicians
For clinicians
Newly published trial reports, phase 3 publications, reviews, and open studies. Every item links to its primary source.
Compiled automatically by Metronomic.com from PubMed and ClinicalTrials.gov. Automated listing. Each item links to its original source. Last refresh: Nov 15, 2026
Newest trial publications
- Clinical trialHaematologica2026 Oct 1Treatment of TP53-mutated myelodysplastic syndrome and acute myeloid leukemia with low-intensity metronomic decitabine and venetoclax.Goldfinger M, et al.
- Phase 3 trialNat Cancer2026 JulLong-term outcomes of adjuvant metronomic capecitabine in locoregionally advanced nasopharyngeal carcinoma: a randomized, controlled, multicenter, phase 3 study.Tao YL, et al.
- Phase 3 trialJCO Glob Oncol2026 JunIntegrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).Kapoor A, et al.
- Clinical trialSignal Transduct Target Ther2026 Apr 15HDAC inhibitor tucidinostat and metronomic capecitabine plus endocrine therapy for patients with HR-positive HER2-negative advanced breast cancer after CDK4/6 inhibitors treatment: clinical findings and exploratory circulating tumor cell and ctDNA biomarker analyses of a multicenter, phase 2 study (SYSUCC-020 trial).Wu HL, et al.
- Clinical trialNat Commun2026 Apr 10Cabozantinib and temozolomide in patients with advanced progressive neuroendocrine tumors: a phase 2 study.Cives M, et al.
- Randomized trialBMC Med2026 Mar 3Neoadjuvant camrelizumab combined with metronomic chemotherapy in patients with advanced esophageal squamous cell carcinoma: a pilot randomized phase 2 trial.Chen Z, et al.
- Clinical trialHead Neck2026 MarA Real-World Phase IV Superiority Trial and Cost-Effectiveness Analysis of the Addition of Low-Dose Nivolumab to Triple Metronomic Chemotherapy Compared to the Paclitaxel Carboplatin Regimen in Recurrent or Metastatic Head and Neck Cancer Patients.Khadela A, et al.
- Clinical trialNeuro Oncol2026 Feb 1Phase I/II and window-of-opportunity study of pamiparib and metronomic temozolomide for recurrent isocitrate dehydrogenase mutant gliomas.Schiff D, et al.
- Clinical trialInt J Cancer2026 Jan 1Clinical and biological determinants of multimodal metronomic chemotherapy efficacy in chemo-refractory gastrointestinal cancers.Spehner L, et al.
- Phase 3 trialLancet Oncol2025 DecMetronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial.Yuan J, et al.
- Clinical trialESMO Open2025 NovMOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.Borcoman E, et al.
- Clinical trialBMC Med2025 Oct 21Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trial.Zhou C, et al.
- Clinical trialBreast2025 OctTremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study.De La Motte Rouge T, et al.
- Randomized trialBreast Cancer Res Treat2025 SepA direct comparison of classical oral Navelbine vs metronomic Navelbine in metastatic breast cancer: results from the Danish Breast Cancer Group's (DBCG) NAME-trial.Brems-Eskildsen AS, et al.
- Clinical trialPediatr Blood Cancer2025 JulResults of the Latin American Pediatric Oncology Group (GALOP) Trial for Patients With Metastatic Ewing Sarcoma: Multicentric Study of Interval-Compressed Multiagent and Metronomic Chemotherapy.Rose A, et al.
Reviews and meta-analyses
- ReviewAdv Drug Deliv Rev2026 Nov 5From acute intervention to chronic management: biopharmaceutical barriers and advanced formulation strategies for peroral metronomic chemotherapy.Dinakar YH, et al.
- ReviewMolecules2026 Nov 3Metabolically Controlled Oncological Treatment: An Evidence-Graded Framework Integrating Metabolic Reprogramming, Targeted Drug Delivery, and Standard Oncological Care.Iyikesici MS, et al.
- ReviewHNO2026 Oct 15[Nonimmunological systemic therapies in head and neck cancer : Cytotoxic, targeted, EGFR-directed, and supportive approaches at ASCO 2026].Blaurock M, et al.
- Systematic reviewCancer Treat Rev2026 SepVinorelbine and low-dose cyclophosphamide as maintenance therapy in the treatment of Ewing sarcoma rationale for the international INTER-EWING-1 trial for Ewing sarcoma patients.Haveman LM, et al.
- ReviewOral Dis2026 Aug 18Tegafur-Uracil (UFUR) as Maintenance Therapy in Resectable and Unresectable Head and Neck Squamous Cell Carcinoma: A Narrative Review.Wang HC and Chu PY
- ReviewCancers (Basel)2026 Aug 3Predictive Biomarkers of Metronomic Chemotherapy Response in Solid Tumors: Chasing an Elusive Signal.Wysocki PJ, et al.
- ReviewCancer Rep (Hoboken)2026 JulMetronomic Chemotherapy in Ovarian Cancer: Current Scenario and AI-Integrated Future Strategies.Chauhan R, et al.
- ReviewCurr Opin Oncol2026 Jul 1From dose to exposure? rethinking fluoropyrimidines as immune checkpoint partners in gastrointestinal cancers.Hendlisz A, et al.
- Systematic reviewJ Neurooncol2026 May 16Should checkpoint inhibitors be reserved for biomarker-selected pediatric brain tumors?Levin-Carrion Y, et al.
- ReviewTransl Cancer Res2026 Apr 30Metronomic chemotherapy combined with immunotherapy in solid tumor: a systematic review.Li S, et al.
Recently updated open trials
- RecruitingPhase 1FranceNCT02897986Study of a Propranolol (HEMANGIOL®) and Oral Metronomic Vinorelbine (NAVELBINE®) Combination for Children and Teenagers With Refractory/Relapsing Solid TumorsAssistance Publique Hopitaux De Marseille
- RecruitingPhase 1, Phase 2FranceNCT06485908Axitinib and Oral Metronomic Etoposide for Pediatric Children and AYA Refractory/Relapsing Medulloblastoma and EpendymomaAssistance Publique Hopitaux De Marseille
- RecruitingPhase 2ChinaNCT06054906Neoadjuvant of Sintilimab Combined Weekly Metronomic Chemotherapy (POLF) for Resectable Locally Advanced Gastric CancerHuashan Hospital
- RecruitingPhase 2FranceNCT06425133Regorafenib in Combination With Multimodal Metronomic Chemotherapy for Chemo-resistant Metastatic Colorectal CancersCentre Hospitalier Universitaire de Besancon
- RecruitingEarly phase 1CanadaNCT06942039Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationC17 Council
- RecruitingPhase 1United StatesNCT05106296Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerTheodore S. Johnson
- RecruitingPhase 2Austria, Czechia, Denmark, and 5 moreNCT01356290Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS TumorsMedical University of Vienna
- RecruitingPhase 2United StatesNCT06997068Methotrexate, Erlotinib, and Celecoxib for the Treatment of Recurrent/Metastatic Head and Neck Cancer in a Rural Midwest United States PopulationMayo Clinic
- RecruitingPhase 2ChinaNCT06787339Capecitabine in Low Risk Triple Negative Breast CancerFudan University
- RecruitingPhase 2United StatesNCT07710534Metronomic Decitabine-Cedazuridine and Venetoclax in R/R AML, HR-MDS, HR/AP MPNVirginia Commonwealth University
Titles appear as published. A listing is not an endorsement, and a single study rarely settles a question. Not medically reviewed. Educational information, not medical advice.
